Reported about 1 month ago
Septerna Inc. saw its shares rise by 19% in their market debut after raising $288 million in an expanded initial public offering. The South San Francisco-based biotech company's shares closed at $21.40, surpassing the IPO price of $18. This robust performance reflects ongoing investor interest in biotech companies, with drug developers raising a total of $3.9 billion through IPOs on US exchanges this year.
Source: YAHOO